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Hydrocephalus can occur in children alone or in combination with other
neurodevelopmental disorders that are often associated with brain overgrowth. Despite
the severity of these disorders, the molecular and cellular mechanisms underlying
these pathologies and their comorbidity are poorly understood. Here, we studied
the consequences of genetically inactivating in mice dual-specificity phosphatase 16
(Dusp16), which is known to negatively regulate mitogen-activated protein kinases
(MAPKs) and which has never previously been implicated in brain development and
disorders. Mouse mutants lacking a functional Dusp16 gene (Dusp16−/−) developed
fully-penetrant congenital obstructive hydrocephalus together with brain overgrowth.
The midbrain aqueduct in Dusp16−/− mutants was obstructed during mid-gestation
by an expansion of neural progenitors, and during later gestational stages by neurons
resulting in a blockage of cerebrospinal fluid (CSF) outflow. In contrast, the roof plate
and ependymal cells developed normally. We identified a delayed cell cycle exit of neural
progenitors in Dusp16−/− mutants as a cause of progenitor overproliferation during mid-
gestation. At later gestational stages, this expanded neural progenitor pool generated
an increased number of neurons associated with enlarged brain volume. Taken together,
we found that Dusp16 plays a critical role in neurogenesis by balancing neural progenitor
cell proliferation and neural differentiation. Moreover our results suggest that a lack of
functional Dusp16 could play a central role in the molecular mechanisms linking brain
overgrowth and hydrocephalus.
Keywords: DUSP16, hydrocephalus, brain overgrowth, megalencephaly, macrocephaly, neurogenesis, neural
differentiation, neuronal progenitors
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INTRODUCTION
Hydrocephalus, estimated to affect 1 in 1000 infants is a
condition caused by abnormal cerebrospinal fluid (CSF) flow
that leads to progressive ventricular dilatation and neural
damage. Most infantile hydrocephalus cases are congenital
(Tully and Dobyns, 2014). Based on the CSF dynamics,
hydrocephalus can be classified as obstructive, resulting from
impeded CSF circulation or non-obstructive, caused by increased
CSF production or impaired CSF resorption (McAllister, 2012;
Tully and Dobyns, 2014; Kahle et al., 2016; Kousi and Katsanis,
2016). Congenital hydrocephalus is particularly difficult to treat
and often result in the poorest neurological outcomes (Kahle
et al., 2016). Although obstruction of CSF flow is the most
common culprit in congenital hydrocephalus, the molecular and
cellular underpinnings of the occlusion are not well understood
(McAllister, 2012; Tully and Dobyns, 2014).
Brain overgrowth has been implicated in a broad range
of neurodevelopmental disorders. Pathohistological changes in
such conditions can be either prominent, as in megalencephaly
syndromes (i.e., brain weight ≥2 standard deviations above
mean), or, subtle, as in autism spectrum disorders (Mirzaa and
Poduri, 2014; Hevner, 2015; Winden et al., 2015). Mutations
affecting growth factor signaling pathways including mTOR and
RAS/mitogen-activated protein kinase (MAPK) pathways have
been identified as major causes of brain overgrowth disorders
(Hevner, 2015). Interestingly, there is a known co-morbidity
of brain overgrowth disorders with hydrocephalus including
megalencephaly syndromes, RASopathies and autism spectrum
disorders (Fernell et al., 1991; Lindquist et al., 2006; Mirzaa
and Poduri, 2014; Winden et al., 2015; Kousi and Katsanis,
2016). However, little is known about the genetic and cellular
mechanisms combining these two pathologies.
Neural progenitor proliferation during embryonic
neurogenesis needs to be tightly regulated, since it is fundamental
for proper brain function. Consequently, dysregulation in the
numbers of forming neurons can cause a broad spectrum of brain
disorders. Neural progenitors initially divide symmetrically to
expand their pool and switch to neurogenic division at the onset
of neurogenesis (Götz and Huttner, 2005). The balance between
self-renewal and cell cycle exit of neural progenitors, and the
generation of the appropriate numbers of postmitotic progeny
is critical for normal brain formation. This process is regulated
by a set of growth factors triggering different signaling cascades,
including the NOTCH,WNT, SHH, BMP and Fibroblast growth
factor (FGF) pathways (Götz and Huttner, 2005; Paridaen and
Huttner, 2014). These cascades maintain extensive cross talks,
whereby MAPKs plays a prominent role in integrating different
signaling pathways (Miloso et al., 2008).
Dual-specificity phosphatases (DUSPs) are a group of
proteins that can dephosphorylate both phosphotyrosine and
phosphoserine/phosphothreonine residues within one substrate
and are major modulators of central signaling pathways. The
best characterized group of DUSPs are MAPK phosphatases,
which currently include 10 members. MAPK phosphatases
that are activated by different extracellular signals, including
growth factors, play a critical role in MAPK pathways by
negatively regulating ERK, JNK and p38 MAPK activity via
de-phosphorylation (Dickinson and Keyse, 2006; Patterson et al.,
2009).
Functions of DUSPs in cancer and immune response are
well documented (Dickinson and Keyse, 2006; Patterson et al.,
2009). However, few DUSPs have been associated with neural
development. DUSP1 and -6 are implicated in cell survival, cell
death and axonal development (Jeanneteau et al., 2010; Finelli
et al., 2013; Collins et al., 2015). Recently DUSP16 was identified
as an axonal preserving factor during development (Maor-Nof
et al., 2016). In contrast, for most other DUSPs there are no data
available on their role in the formation of the nervous system
(Bermudez et al., 2010). Interestingly, in each of these reports,
DUSP activity was mediated by modifying the activity of ERKs
rather than JNK or p38 MAPK.
DUSP16 preferentially dephosphorylates JNKs and
p38 MAPK (Masuda et al., 2001; Matsuguchi et al., 2001),
and has been implicated in carcinogenesis and in maintaining a
balanced immune response by modulating the magnitude and
duration of effector functions of innate and adaptive immune
cells (Niedzielska et al., 2014). Dusp16-deficient gene trap mice
die perinatally without gross developmental abnormalities
(Niedzielska et al., 2014). However, the role of Dusp16 in CNS
morphogenesis or disorders was not previously explored.
Here we report that the genetic inactivation ofDusp16 leads to
congenital obstructive hydrocephalus and brain overgrowth. The
neural progenitor pool was increased In Dusp16−/− mutants,
due to a delay in neural differentiation. The expanded neural
progenitors obstructed the midbrain aqueduct, and later during
embryogenesis give rise to an increased number of neurons
causing brain overgrowth.
MATERIALS AND METHODS
Breeding of Mouse Mutant Colony
All mice were housed in a temperature-controlled (21–23◦C)
environment, under a 12-h light/dark cycle and had free access to
food and water in a pathogen-free animal facility. All procedures
and experimental protocols conducted on the animals were
approved by the Institutional Animal Care and Ethics Committee
at Ben-Gurion University of the Negev (Approval # IL-53-09-
2016). The generation of Dusp16 gene trap mouse line has
been described in detail elsewhere (Niedzielska et al., 2014).
Dusp16 gene trap mouse mutants (Dusp16−/−) were kept
in a pure C57BL/6 genetic background and die perinatally
as homozygotes (Niedzielska et al., 2014). C57BL/6 mice
heterozygous for Dusp16 (Dusp16+/−) were mated to obtain
homozygous-deficient Dusp16 embryos.
Genotyping of adult animals and embryos for the Dusp16
locus and the β-Geo expression cassette was performed by
polymerase chain reaction (PCR) analysis on gDNA isolated
from tail biopsies as described previously (Niedzielska et al.,
2014). The sequences of the primers for Dusp16 genotyping
are: RL528: 5′-CGCTCTTACCAAAGGGCAAACCC-3′,
RL535: 5′-CCATCTCATGGCAGAGGAGTGACT-3′, RL536:
5′-GACCTGTGCATAACTGGCCCTACTAC-3′. The expected
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size for the PCR product of a wild type (WT) allele is 450 bp, the
size of the LacZ knock-in allele is 650 bp.
BrdU Administration
To label cells during the S-phase of the cell cycle, the DNA
synthesis marker, 5-bromo-2′-deoxyuridine (BrdU; Sigma, cat #
B5002) was dissolved in sterile 0.9% NaCl solution at a
concentration of 10 mg/ml. Timed mated pregnant females were
given a single intraperitoneal (i.p.) injection of BrdU solution at
a concentration of 50 mg of BrdU/kg of body weight. Pregnant
females were sacrificed and embryos were collected 1 h after the
i.p. injection (to label cells during S-phase) or 24 h after the i.p.
injection (to label cells in S-phase and postmitotic cells that exited
the cell cycle in the previous 24 h) and processed for paraffin
embedding according to standard protocols.
Dissection, Embedding and Histology of
Mouse Embryos
Heterozygous females were caged together with heterozygous
males during the 12-h dark period. The day of vaginal plug
detection was considered as day 0.5. Timed mated pregnant
females at different stages of pregnancy from E11.5 to E18.5 were
euthanized by isoflurane. Embryos were dissected free of
maternal tissues in cold phosphate-buffered saline pH 7.4
(1× PBS), decapitated and heads (E11.5–E15.5) or brains
(E16.5–E18.5) were placed in individual tubes and fixed in
4% paraformaldehyde in 1× PBS overnight at 4◦C. Following
fixation, tissue samples were washed in 1× PBS, dehydrated
through the series of graded ethanol, isopropanol and toluene
to displace the water, and then infiltrated with Paraplast Plus
tissue embedding medium (Leica). For the embryonic phenotype
analysis only homozygousDusp16−/− were used.WT littermates
were used as a control for Dusp16−/− mutants.
For histological analysis, paraffin blocks were sectioned at
5 µm in thickness and stained with Hematoxylin/Eosin (H&E)
by standard methods. Tissue morphology was evaluated by
light microscopy (Olympus U-PMTVC, Japan). Representative
sections are shown based on at least three animals per genotype
group.
LacZ Staining Using X-Gal
Heterozygous Dusp16+/− and WT littermate embryos were
generated through mating of heterozygousDusp16+/− male with
WT females. Pregnant females at different stages of pregnancy
were sacrificed and E11.5 or E12.5 embryos were dissected in
1× PBS. Embryos were decapitated and fixed in 4% PFA/PBS for
1 h. Heads of embryos were then washed in 1× PBS followed by
3 × 20 min washes in detergent wash solution (2 mM MgCl2,
0.01% sodium deoxycholate, 0.02% NP40 in 1× PBS pH 7.4).
Detergent wash solution was replaced by X-gal staining solution
(1 mg/ml X-gal, 5 mM potassium ferricyanide, 5 mM potassium
ferrocyanide in detergent wash solution) overnight at 37◦C.
The following day, the staining solution was removed and
samples were washed in 1× PBS, post-fixed in 4% PFA/PBS
for 3 h and again washed in 1× PBS. Fixed embryos were then
imaged with a microscope or embedded in 4% low melting
agarose (Sigma Aldrich) and processed for vibratome sectioning
(100 µm thickness). Slices were mounted on SuperfrostPlusr
glass slides (Thermo Scientific), glued with Immu-MountTM
(Thermo Scientific) and evaluated using Olympus U-PMTVC
microscope.
Immunohistochemistry on Paraffin
Sections
For immunohistochemistry analysis, paraffin sections (5 µm)
were first de-waxed using xylene washes (3 × 5 min each),
subsequently re-hydrated in 100% ethanol (2 × 5 min each),
followed by decreasing series of ethanol (95%, 70%, 50%,
1 × 5 min each) and ddH2O (2 × 5 min each). After antigen
retrieval in boiling citric acid (pH 6) for 10 min, sections were
blocked in 4% normal goat serum (NGS) for 1 h and incubated
in primary antibodies diluted in blocking buffer overnight at
4◦C. Primary antibodies used: mouse anti BrdU (1:500, Sigma
B2531), mouse anti BRN-3A (1:300, SantaCruz sc-8429), rabbit
anti CAS-3 (1:200, Cell Signaling D175), rabbit anti CCND2
(1:200, SantaCruz sc-593), rabbit anti KI67 (1:100, Abcam
ab16667), rabbit anti LMX1A (1:400, Millipore AB10533), rabbit
anti LMX1b (1:1000, gift from Dr. C. Birchmeir, Germany),
rabbit anti MAP-2 (1:100, SantaCruz sc20172), mouse anti
N-CAD (1:200, BD 610920), mouse anti Nestin (1:10, DSHB
rat-401), mouse anti NEUN (1:100, CHEMICON MAB377x),
rabbit anti OCLN (1:25, Invitrogen 71-1500), mouse anti p-ERK
(1:100, Sigma M9692), rabbit anti p-JNK (1:100, Promega
V793B), rabbit anti p-P38 (1:1000, Cell Signaling 4511),
rabbit anti Reissner’s fiber (RF; 1:200, kindly provided by
Dr. Esteban Rodriguez, Austral University of Chile), rabbit
anti RFX3 (1:300, Sigma HPA035689), rabbit anti Zonula
occludens-1 (ZO-1; 1:100, Invitrogen 40-2200), rabbit anti PHH3
(1:1000, Millipore 06-570), rabbit anti-SOX2 (1:400 Millipore
AB5603), mouse anti-HUC/D (1:800 Molecular probes A-
21271). The next day, sections were washed for in 1× TBST
and incubated in Fluorophore conjugated (Cy2- and/or Cy3-
, 1:100, Jackson Laboratories) secondary antibodies diluted
in 1× TBST, for 1 h at room temperature in the dark.
Finally, sections were washed in 1× TBST and mounted using
regular Immu-MountTM. Biotinylated secondary antibodies were
visualized with the Vectastain ABC immunoperoxidase kit
(Vector Laboratories, PK-6200) using 3,3′-diaminobenzidine
tetrahydrochloride (DAB) substrate.
For detection of BrdU incorporation, sections were
re-hydrated and antigen retrieved as described above. After
antigen retrieval step, sections were immediately treated with
2N HCl for 30 min at 37◦C. Sections were then washed in 1×
PBS/0.05% Tween-20, incubated in 1× PBS/0.5% Triton for
1 h and blocked in blocking buffer (1% BSA in 1× PBS/0.05%
Tween-20) for 1 h at room temperature, and incubated in
anti-BrdU antibody diluted in blocking buffer overnight at 4◦C.
mRNA in Situ Hybridization
For mRNA in situ probes forDusp16, the sequence that had been
published by GenePaint1 was used. Dusp16 sequence of 1012 bp
was amplified from cDNA pool by PCR using following primers:
1http://www.genepaint.org
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Forward primer: 5′-CACTCAGATATTCTGGCTCCC-3′,
Reverse primer: 5′-CTAGACATGGTAGTGGTGATGGC-3′.
Cloning of the PCR product into the plasmid was performed
using pGEMr-T Easy Vector (Promega, A1360) following the
manufacturer’s standard protocol. Standard in vitro transcription
reactions for in vitro RNA synthesis (sense and antisense) were
performed using 10× DIG RNA Labeling Mix following the
manufacturer’s standard protocol. Tissue preparation and
in situ hybridization were processed as described previously
(Stylianopoulou et al., 2012; Sherf et al., 2015).
Total Brain Tissue Surface Quantification
Formeasurement of total brain tissue surface, H&E serial coronal
sections (5 µm) throughout the entire brain (every 50 µm of
E12.5 and E13.5 and every 60 µm of E16.5) were captured with
an Olympus U-PMTVC microscope (Japan). Total surface area
was quantified using ImageJ software by outlining the entire
brain surface, excluding the ventricles, and then applying the area
measurement function.
Thickness of the Cortex Quantification
The thickness of the cortical layers was measured at the level
of the dorsal hippocampus (future sensorimotor cortex) as
described previously (Bible et al., 2004). Using a 5× objective,
three consecutive H&E coronal sections (5 µm) were captured.
Cortical region boundaries were defined by straight lines
extending perpendicularly from the corticostriatal boundary and
the dorsomedial apex to the pial surface. Ten lines placed on
each of three consecutive sections spanning each cortical region
were made. The length of perpendicular lines extending from the
ventricular surface to the pial surface was measured using Adobe
Illustrator software.
Cell Counting
For E12.5 embryos, the total number of cells (BrdU) was obtained
by counting cells from every tenth section at 5 µm thickness. For
E13.5 embryos, cells from one-half of the sections separated at
the dorsal midline were counted on every tenth section (BRN3A)
or every twentieth section (quitting fraction) at 5 µm thickness.
For quantification of phosphorylated p38+ MAPK cells in the
region of occlusion demarked by the posterior commissure (PC)
at E13.5, all cells present in ventricular zone (VZ) were counted
on every tenth section at 5 µm thickness. For E18.5 embryos,
the total number of cells (BRN3A) from one-half of the sections
separated at the dorsal midline was counted on every 56th
(BRN3A) at 5 µm thickness. The total number of positively
labeled cells was determined by summing the values in all tissue
sections.
Statistical Analysis
Two-tailed paired sample Student’s t-test and two-tailed
unpaired Student’s t-test were performed to test the significance
of difference in numerical data as appropriate. The data
in the text and the error bars on the figures represents
mean ± standard error of the mean (SEM). Every significant
change and interaction was marked by an asterisk between the
bars (∗p< 0.05, ∗∗p< 0.01 and ∗∗∗p< 0.001).
RESULTS
Dusp16 Is Highly Expressed in the
Ventricular Zone of the Embryonic Mouse
Brain, Suggesting its Implication in
Neurogenesis
In order to study the role of Dusp16 in neural development,
we visualized its expression pattern during embryogenesis.
To do so, we used mouse mutants with a beta-Galactosidase-
Neomycin transferase (beta-Geo) gene trap insertion in
the Dusp16 locus, generating a Dusp16-beta-Geo mRNA
(Niedzielska et al., 2014). The enzymatic activity of the
protein encoded by this transcript was used to visualize
the pattern of Dusp16 expression in E11.5 and E12.5 and
E15.5 embryos heterozygous for Dusp16 (Dusp16+/−). Adult
Dusp16+/− mice are viable and fertile without apparent
morphological or behavioral changes (Niedzielska et al., 2014).
We combined the analysis of these heterozygote mutants
with mRNA in situ hybridization on WT animals performed
by us and a publicly available database (Magdaleno et al.,
2006).
At E11.5 expression of β-galactosidase was abundant in
the CNS, particularly in the forebrain and dorsal midbrain
(Figure 1A). Serial rostral (R) to caudal (C) coronal
vibratome sections of X-Gal stained Dusp16+/− mouse
heads showed that β-galactosidase was expressed in the VZ
of the developing brain (Figures 1B–K). The absence of
endogenous β-galactosidase activity was demonstrated in
WT littermates that underwent the same protocol in parallel
but failed to show any signal (data not shown). At E12.5 we
complemented X-Gal stainings (Figures 1G′–K′) with mRNA
in situ hybridization (Figures 1G–K) performed in our lab
and found that both methods demonstrated a consistent
expression pattern of Dusp16 in the VZ of the developing
brain at this stage. At E13.5 Dusp16 mRNA was expressed
predominantly in the VZ of the developing brain (Figures 1L,M)
but not in the choroid plexus (CP; Figure 1N). Also at
E15.5, Dusp16 gene expression was mostly confined to the
VZ as seen in our mRNA in situ hybridization experiments
(Figures 1O,Q), the publicly available database (Figures 1P,R)
and our X-Gal stainings (Figures 1P′,P′′,R′,R′′). In summary,
Dusp16 was highly expressed in the VZ of the forming brain,
suggesting a potential role for this gene in modulation of
neurogenesis.
Aqueductal Stenosis Causes Congenital
Obstructive Hydrocephalus in Dusp16−/−
Mutants
In order to investigate the functional relevance of the Dusp16
expression in vivo, we studied brain development in mice
lacking a functional Dusp16 gene (Dusp 16−/−). Homozygous
Dusp16−/− mutants develop without gross morphological
abnormalities in organ systems outside the CNS, and die
shortly after birth of unknown causes (Niedzielska et al., 2014).
Brain ventricles of Dusp16−/− mutants at E12.5 exhibited
no obvious morphological abnormalities (Figures 2A–C′).
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FIGURE 1 | Dual-specificity phosphatase 16 (Dusp16) is highly expressed in the VZ of the embryonic mouse brain. (A) X-Gal staining of an E11.5 embryo head
expressing the LacZ gene under the endogenous Dusp16 promoter. Dusp16 is strongly expressed in the forebrain and dorsal midbrain at E11.5. (B–K′) Serial rostral
to caudal coronal sections of E11.5 and E12.5 Dusp16+/− embryos demonstrate strong expression of Dusp16 in the VZ of developing brains shown by lacZ staining
and mRNA in situ hybridization. (L–N) mRNA in situ hybridization using a Dusp16 mRNA probe demonstrates that Dusp16 continues to be expressed also at
E13.5 and E15.5 (O–R), that corresponds to lacZ staining at E15.5 (P′,P′′,R′,R′′). CP, choroid plexus; F, forebrain; IIIV, third ventricle; LV, lateral ventricle; M,
midbrain; VZ, ventricular zone; GE, ganglionic eminence; Aq, Aqueduct of Sylvius.
However, starting from E13.5, mutants showed enlarged lateral
and third ventricles (Figures 2D–F′). At E16.5 massive dilatation
of the lateral as well as third ventricle was apparent in
Dusp16−/− mutants (Figures 2G–I′). The phenotype was fully
penetrant.
Congenital hydrocephalus can be caused by increased
production of CSF by the CP, impaired absorption of CSF
in the blood stream, or as in the majority of congenital
cases, by obstruction of CSF flow (McAllister, 2012; Tully
and Dobyns, 2014; Kahle et al., 2016; Kousi and Katsanis,
2016). To study whether Dusp16 could be involved in
the development and function of the CP, we analyzed its
expression there at E13.5 mRNA in situ hybridization did
not reveal Dusp16 expression in the CP of WT embryos
(Figure 1N). Moreover, the overall morphology of the CP
at E14.5 was normal in Dusp16−/− mutants (Figures 2J–M),
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FIGURE 2 | Aqueductal stenosis causes congenital obstructive hydrocephalus in Dusp16−/− mutants. Hematoxylin/Eosin (H&E) serial rostral (R) to caudal (C)
coronal sections from E12.5, E13.5 and E16.5 wild types (WTs) and Dusp16−/− mutants are shown with each pair of sections representing approximately the same
coronal plane. (A–C′) At E12.5, Dusp16−/− mutants show no changes in the ventricular size. (D–F′) At E13.5 a subtle enlargement of the lateral and third ventricle
starts to be visible in Dusp16−/− mutants. (G–I′) At E16.5 enlargement of the ventricles are clearly visible (arrows). Scale bars: (C′,F′) 500 µm; (I′) 200 µm.
(J–M) H&E staining of coronal hemisections through LV of WT and Dusp16−/− brains at E14.5. The overall morphology of CP appears normal in Dusp16−/− mutants
(L,M) compared with control littermates (J,K). Higher magnification of the areas marked by boxes shows that cytoplasmic volume of the CP epithelial cells in
Dusp16−/− mutants (M) is unperturbed compared with WT (K). (N,N′) H&E staining of coronal sections through the fourth ventricle of WT and Dusp16−/− heads at
E15.5 demonstrating the same size of the fourth ventricle in Dusp16−/− compared with WT (arrowhead). (O–R′) H&E staining of coronal sections through the Aq of
WT and Dusp16−/− heads at E13.5 revealed a near complete obstruction in Dusp16−/− mutants. Scale bars: (L) 500 µm; (K) 20 µm; (N′) 500 µm; (R′) 200 µm.
Aq, Aqueduct of Sylvius; C, caudal; LV, lateral ventricle; IIIV, third ventricle; PC, posterior commissure; R, rostral; CP, choroid plexus.
thereby suggesting that overproduction of CSF is unlikely
to have caused the observed hydrocephalus. In Dusp16−/−
mutants at E15.5 dilatation of the fourth ventricle was not
seen (Figures 2N,N′), though enlargement of the lateral and
third ventricles were already visible at this developmental stage.
This suggests that impaired reabsorption of CSF into the
venous blood stream was not responsible for the hydrocephalus
in these animals. In contrast, the midbrain aqueduct of
Sylvius (Aq) was obstructed from 13.5 onwards compared to
the open aqueduct in WTs (Figures 2O–R′). In conclusion,
these findings indicate that the hydrocephalus observed in
the Dusp16-deficient embryos was caused by aqueductal
stenosis.
Dusp16-/- Mutants Show an Increase in
Brain Parenchyma
During embryogenesis, Dusp16−/− mutants exhibited an
increase in brain parenchyma (Figures 3A–C′). Quantification
of the brain surface area, excluding the ventricles, of Dusp16−/−
mutants, revealed a significant increase in brain tissue volume
(paired sample Student’s t-test, t(4) = 2.77; p = 0.034;
Figure 3D). Based on prominent Dusp16 expression in the
Frontiers in Molecular Neuroscience | www.frontiersin.org 6 November 2017 | Volume 10 | Article 372
Zega et al. Dusp16 in Neurogenesis and Neurodevelopmental Disorders
FIGURE 3 | Dusp16−/− mutants show an increase in brain tissue. (A–C′) Representative H&E staining of WT and Dusp16−/− head sections along the rostro-caudal
axis (R->C) at E13.5 indicates an increase in neural tissue in Dusp16−/− mutants. (D) A two tailed paired-samples t-test shows a significant increase in the total brain
surface, excluding the ventricles, of Dusp16−/− mutants at different embryonic stages compared with control littermates. (E,E′) H&E coronal sections of the
mesencephalon illustrate enlarged superior colliculus of E18.5 Dusp16−/− mutants compared with WT (doted lines). (F,F′) Hemisections visualizing gabaergic
neurons using Gad1 mRNA probes for in situ hybridization indicate that there is an increase in Gad1 signal strength in mutants. (G,G′) Hemisections visualizing
glutamatergic neurons using Vglut2 mRNA probes for in situ hybridization indicate that there is an increase in Vglut2 signal strength. (H–I) Hemisectioins visualizing
BRN3A+, marking in the dorsal midbrain postmitotic glutamatergic neurons indicate a significant increase of these cells in Dusp16−/− mutants WT (n = 4;
Dusp16−/−; n = 4). (J,J′) H&E coronal hemisections at the level of future sensorimotor cortex of E18.5 WT and Dusp16−/− mutants illustrate an increase in cerebral
cortex thickness in mutants. (K) Higher magnification of the mediolateral cortex marked by the box in (A) illustrate cortical thickening in Dusp16−/− mutants.
(L) Quantification of total neocortical area shows significant increases in overall cortical thickness of Dusp16−/− mutants. All the values are normalized to 100%
which represents the average value for cortex thickness in WT littermate controls (n = 3; Dusp16−/−; n = 4). Scale bar: (C′,E) 200 µm; (D) 50 µm; (H) 500 µm. C,
caudal; CP, cortical plate; IZ, intermediate zone; R, rostral; SVZ, subventricular zone; SP, sublate; VZ, ventricular zone; LV, lateral ventricle; IIIV, third ventricle; Aq,
Aqueduct of Sylvius.
dorsal midbrain and the midbrain aqueductal stenosis, we
examined this brain region in more detail. The superior
colliculus, in the dorsal midbrain, was clearly enlarged in
Dusp16−/− mutants (Figures 3E,E′). Moreover, the strength
of the in situ hybridization signal for Vglut2 and Gad1,
marking glutamatergic and gabaergic neurons respectively,
were increased in the dorsal midbrain, without any apparent
changes in the size ratio of both populations (Figures 3F–G′).
The quantification of glutamatergic neurons using BRN3A as
a marker for postmitotic glutamatergic neurons indicated a
29.13% increase in these cells in Dusp16−/− mutants (Student’s
t-test, p = 0.034; Figures 3H–I). The thickness of the posterior
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FIGURE 4 | The midbrain roof plate and ependymal cells develop properly in the absence of Dusp16. Cell type- and intercellular junction-specific antibodies were
visualized by fluorescent or peroxidase-conjugated secondary antibodies in order to study the intactness of the dorsal diencephalon/mesencephalon of WTs (A–F)
and Dusp16−/− (A′–F′) at E12.5 and E13.5. (A,A′) LMX1B at the roof plate is not altered in mutants. (B,B′) The neuroepithelial marker OCLN was not detected in
mutants at E12.5, indicating the proper differentiation of radial glia cells from neuroepithelial cells. (C,C′) Adherens junctions did not show any differences between
genotypes, as assessed by N-CAD expression at the apical surface of radial glia cells at E13.5. (D–E′) The adherens junction molecule Zonula occludens-1 (ZO-1),
expressed on the apical side of the radial glia cells that face the lumen was present and showed the dorso-ventral expression gradient in mutants as well as in WTS.
(F,F′) RFX3 required for the differentiation of ependymal cells did not show any aberrations in Dusp16−/− mutants. Scale bar: 200 µm. Aq, Aqueduct of Sylvius.
parts of the cerebral cortex was reduced in mutants due to the
increased pressure caused by the hydrocephalus. In contrast,
the rostral parts of the cerebral cortex in the mutant mice
showed at the level of the future sensimotor cortex enlarged
ventricular, subventricular and intermediate zones (VZ, SVZ,
IZ; Figures 3J–K). The total neocortical area was significantly
enlarged in the Dusp16−/− mutants by 23.36% (Student’s
t-test, p = 0.015; Figure 3L). Taken together, these results
show that a mutation in Dusp16 leads to an increase in brain
volume, and support involvement of Dusp16 in the regulation of
brain size.
The Midbrain Roof Plate and Ependymal
Cells Develop Properly in the Absence of
Dusp16
In order to study the mechanisms responsible for the observed
closure of the aqueduct, we assessed the integrity of cellular
components at the midbrain aqueduct frequently associated
with hydrocephalus in other animal models. The roof plate
is an important organizer for midbrain development, and
perturbations in this structure have been shown to cause
hydrocephalus (Fernández-Llebrez et al., 2004). To determine
if the roof plate is properly formed in Dusp16−/− mutants,
we studied the expression of the transcription factor LMX1B.
Immunostaining was performed at E12.5, shortly before onset
of ventricular enlargement in Dusp16−/−. Using LMX1B
as a roof plate marker, no abnormalities were observed
(Figures 4A,A′). Next, we assessed the expression of OCLN,
a tight junction marker, exclusively expressed on the apical
side of neuroepithelial cells, and not expressed by radial glia
cells (Götz and Huttner, 2005). WT and Dusp16−/− roof
plate cells did not express OCLN at E12.5, indicating that
neuroepithelial cells had properly differentiated into radial
glial cells (Figures 4B,B′). Radial glial cells form intercellular
junctions at the apical side and basal lamina at the basal
side which are essential for maintenance of the neural tube
morphology. In order to investigate if this inner barrier was
properly formed, we assessed the presence of the adherens
junction molecule, N-cadherin (N-CAD). Although the dorsal
midline exhibited structural differences in Dusp16−/− mutants,
N-CAD expression was found at the apical surface of radial
glia cells of Dusp16−/− mutants at E13.5 (Figures 4C,C′).
We also assessed the presence of another adherens junction
molecule ZO-1, that is expressed on apical side of radial glia
cells that face the lumen (Petrov et al., 1994). The lack of
Dusp16 in mutants did not affect the presence or dorso-
ventral expression gradient of the apical junction molecule
ZO-1 (Figures 4D–E′). Finally, we examined RFX3, required
for the differentiation of ependymal cells that contribute to CSF
homeostasis, and who’s absence causes congenital hydrocephalus
in mice (Baas et al., 2006). We observed expression of RFX3 at
E15.5 in WT and Dusp16−/− mutants and found no difference
(Figures 4F,F′). In summary, neither dorsal mis-patterning
nor changes in the ependymal development that could have
accounted for the aqueductal obstruction were observed in
Dusp16−/− mutants.
The Midbrain Sylvian Aqueduct in
Dusp16−/− Mutants Is Obstructed by
Neurons
The subcommissural organ (SCO), located at the entrance of
the midbrain aqueduct, is a brain gland producing RF that
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FIGURE 5 | The sylvian aqueduct in Dusp16−/− mutants is obstructed by neurons. (A–B′) Immunostaining of E15.5 mouse SCO reveals RF immunoreactivity (white
arrow) directly at the luminal surface (red dotted line) in WT (A) compared with Dusp16−/− mutants where RF (white arrow) did not reach the lumen (red dotted line;
A′ ). In WTs littermates, the midline SCO (white dotted circle) was devoid of neurons (B) compared to Dusp16−/− mutants, where NEUN+ cells were found in the
midline (red arrow; B′ ), in the region that was devoid of RF. (C–Q′) Consecutive coronal sections from rostral (R) to caudal (C) levels of WT and Dusp16−/− at E16.5.
(C–E′) H&E staining, (F–H′) DAPI staining, (I–K′) RF immunoreactivity, (L–N′) NEUN immunoreactivity, (O–Q′) MAP-2 immunoreactivity, indicate the site of
obstruction in Dusp16−/− is filled with neurons (red arrow). Red dotted line in (A,A′,M,M′,F,F′) indicates ventricular lumen in WTs and closed lumen in mutants. White
dotted circle in (B,M,M′,N,N′,P) indicate SCO in WTs and mutants. Red arrows in (B′,M′,P′) indicate ectopic neurons in the midline of Dusp16−/− mutants. Scale
bars: (A′) 100 µm; (C–Q′) 200 µm. Aq, Aqueduct of Sylvius; SCO, subcommisural organ.
is critical to prevent the collapse of the aqueduct (Vio et al.,
2000). Although RF was made by Dusp16−/− mutants at the
site of obstruction, it did not reach the lumen (Figures 5A,A′).
Unexpectedly, the obstructed area in mutants, directly ventral
to the RF producing cells, was filled with neurons, marked by
NEUN (Figures 5B,B′). We then studied consecutive sections
of E16.5 WT and Dusp16−/− mutants stained with H&E, DAPI
visualizing cell nuclei, MAP-2 and NEUN as neuronal markers
and RF. Although at the site of obstruction SCO cells seemed
to be missing, a significant increase in SCO cells directly
posterior to the stenosis indicated that SCO had been relocated
(Figures 5C–H′). This finding was further supported by using
an RF specific antibody (Rodríguez et al., 1984; Figures 5I–K′),
indicating that RF were formed, but posteriorly displaced.
The ectopic expression of the neuronal markers, MAP-2 and
NEUN to the midline of Dusp16−/− mutants (Figures 5L–Q′),
which in WT littermates was devoid of neurons, suggests that
an increase in neurons has caused the dislocation of SCO
cells. In sum, the dorsal midline, normally free of neurons,
is filled with neurons, at the site of occlusion in Dusp16−/−
mutants.
A Delayed Cell Cycle Exit of Neural
Progenitors in Dusp16−/− Mutants Is the
Cause of the Expanded Neural Progenitor
Pool
To better understand the role of Dusp16 in neurogenesis and
how aberrations in this process may cause hydrocephalus, we
analyzed proliferation and differentiation of neural progenitors
in the dorsal midbrain. Mutants were examined at E11.5 and
E12.5, 1 and 2 days before the midbrain aqueduct is obstructed
by overproliferating cells (Figures 6A–E′).
To investigate progenitor proliferation, we assessed the
number and position of nuclei entering S-phase. Timed-mated
pregnant females were given a single intraperitoneal (i.p.)
injection of BrdU at E11.5 and E12.5, and sacrificed 1 h later.
At E11.5 no changes in cell proliferation were observed in
mutant brains compared to control littermates (Figures 6A,A′).
However, at E12.5, 1 day before the onset of ventricular
enlargements in Dusp16−/− mutants, we observed a significant
increase in the number of proliferating radial glia cells in
Dusp16−/− mutants compared to WTs (Figures 6B,B′). The
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FIGURE 6 | A delayed cell cycle exit of neural progenitors in Dusp16−/− mutants is the cause of the expanded neural progenitor pool. (A,A′) Immunofluorescence of
coronal sections for 5-bromo-2′-deoxyuridine (BrdU) through the dorsal midbrain after 1 h BrdU pulse in WT (A) and Dusp16−/− (A′) E11.5 embryos.
(B–E) Representative coronal sections through the dorsal midbrain at E12.5 preceding the onset of aqueductal obstruction. (B,B′) Immunofluorescent analysis for
BrdU after 1 h BrdU pulse in WT (B) and Dusp16−/− (B′) E12.5 embryos showing increase in the number of proliferating radial glia cells in Dusp16−/− mutants.
(C,C′) Immunofluorescent analysis of PHH3+ cells reveal increased number of luminal mitotic cells in Dusp16−/− mutants compared with WT control littermates.
(D,D′) Immunofluorescent analysis of CCND2+ cells indicates increased number of the cells going through the G1 phase of the cell cycle in Dusp16−/− mutants.
(Continued)
Frontiers in Molecular Neuroscience | www.frontiersin.org 10 November 2017 | Volume 10 | Article 372
Zega et al. Dusp16 in Neurogenesis and Neurodevelopmental Disorders
FIGURE 6 | Continued
(E,E′) No change in apoptosis as measured by phosphorylated CAS-3
immunostaining. Arrow in (E) indicates CAS-3+ cell in WT. (F–G′) At the site of
occlusion at E14.5, SOX2+ proliferative cells fill the midbrain aqueduct
surrounded by HuC/D+ early neurons. (F′,G′) represent higher magnification
of the region depicted by a square in (F,G). (H–I′) Double immunofluorescence
of the midbrain posterior to the site of obstruction. KI67 (red) and BrdU (green)
after 24 h BrdU pulse was used to calculate the fraction of cells exiting the cell
cycle at E13.5 in the midbrain. (I,I′) Double immunofluorescence for KI67
(green) and BRN3A (red) of WT and Dusp16−/− E13.5 embryos.
(J) Quantification of BrdU+ cells throughout entire dorsal midbrain at
E12.5 shows significant increase in Dusp16−/− mutant mice at E12.5 (WT,
n = 3; Dusp16−/−; n = 4). Scale bar: 200 µm. (K) Quantification of the fraction
of cells leaving the mitotic cycle (quitting fraction: percentage of the number of
BrdU+/KI67− cells among the total of BrdU+ cells). In Dusp16−/− mutants,
the number of cells that leave the cell cycle is significantly reduced compared
with control littermates (WT, n = 3; Dusp16−/−; n = 4). (L) Quantification
BRN3A+ cells shows significant reduction in Dusp16−/− mutant mice at E13.5
in the midbrain (WT, n = 3; Dusp16−/−; n = 4). M, midbrain; Aq, Aqueduct of
Sylvius.
number of BrdU+ cells was significantly increased throughout
the entire dorsal midbrain in Dusp16−/− mutants by 32%
(Student’s t-test, p = 0.0058, n = 3 either genotype; Figure 6J).
Complementing these findings, there was inDusp16−/− mutants
an increase in metaphase cells distributed along the luminal
surface as indicated by an increase in the mitotic marker
PHH3 (Figures 6C,C′). Moreover, CCND2, which promotes
progression through the G1 phase of the cell cycle, was increased
in Dusp16−/− mutants at E12.5 (Figures 6D,D′). In contrast,
the mutants did not show any changes in the level of the
apoptotic marker phosphorylated Caspase-3 (CAS-3) at E12.5
(Figures 6E,E′). Co-labeling for SOX2, a marker for proliferative
nuclei and HuC/D as an early neuronal marker at E14.5,
demonstrated that the aqueduct was filled and obstructed with
SOX2+ neural progenitors (Figures 6F–G′).
To more closely examine the role of Dusp16 in neural
differentiation, we monitored cell cycle exit of neural progenitors
in the dorsal midbrain. This was done by quantifying the
fraction of cells leaving the mitotic cycle. The ‘‘quitting fraction’’
was calculated as the percentage of BrdU+/KI67− cells among
the total BrdU+ cells, subsequent to a single i.p. injection of
pregnant dams at E12.5 with BrdU and sacrifice 24 h later.
Using this approach, BrdU+ cells co-labeled with the mitotic
marker, KI67, were identified as still dividing cells. Cells that
were BrdU+/KI67− where those, that had exited the cell cycle
within the previous 24 h (Figures 6H,H′; Lahti et al., 2011). The
percentage of cells exiting the cell cycle in Dusp16-deficient mice
was significantly reduced by 18.76% (Student’s t-test, p = 0.0149;
Figure 6K).
Since this quantitative analysis suggested a shift in progenitor
proliferation, we decided to assess the number of differentiated
postmitotic glutamatergic BRN3A+ in the dorsal midbrain at
E12.5 (Figures 6I,I′). Indeed, in contrast to later embryonic
stages (Figures 3H,I), the number of BRN3A+ cells was
significantly reduced by 17.18% in Dusp16-deficient mice at
midgestation (Student’s t-test, p = 0.0080; Figures 6I,I′,L). We
conclude that lack of Dusp16 leads to an increase of the neural
progenitor pool, by means of decreased cell cycle exit.
FIGURE 7 | In Dusp16−/− mutants the numbers of phospho-p38 positive
cells was increased together with the expanded progenitor pool.
(A,A′) Immunohistochemical staining of coronal sections through the dorsal
midbrain of E13.5 embryos visualizing phosphorylated p38 mitogen-activated
protein kinase (MAPK), phospho-JNK, and phospho-ERK indicate that there is
a strong phosphorylated p38 MAPK staining in the VZ of Dusp16−/− mutants
compared to control littermates. (B) There is a significant increase in
phospho-p38 MAPK positive cells in mutants (WT, n = 3; Dusp16−/−; n = 3)
(C,C′). In contrast, phospho-JNK is only found in a few cells in the ventricular
lining (arrowheads), with no changes between the genotypes. (D,D′) No signal
is detectable for phospho-ERK in WTs as well as in Dusp16−/− mutants.
Scale bar: 200 µm. PC, posterior commissure.
In Dusp16−/− Mutants the Numbers of
Phospho-p38 Positive Cells Was Increased
Together with the Expanded Progenitor
Pool
Since ERK, JNK and p38 MAPK are the major substrates for
DUSPs, we assessed their phosphorylation in the dorsal midbrain
at E13.5, when the hydrocephalus is first manifest (Bermudez
et al., 2010). Strong phosphorylated p38 MAPK staining was
observed concentrated in the VZ of mutants (Figures 7A,A′).
Comparing WTs with mutants revealed a significant increase in
the number of phospho-p38 MAPK positive cells in the VZ of
the latter by 37.61% (Student’s t-test, p = 0.008; Figure 7B). In
contrast, only a few phospho-JNK positive cells were observed in
this region in both, WTs and Dusp16−/− mice, without apparent
differences between genotypes despite the strong increase in
ventricular cells (Figures 7C,C′). phospho-ERK staining was not
detected in the region of interest (Figures 7D,D′). In conclusion,
these data suggest that the MAPK most likely involved in the
Dusp16−/− phenotype is p38 MAPK.
DISCUSSION
Overproliferation Causing Congenital
Obstructive Hydrocephalus in Dusp16−/−
Mutants
Hydrocephalus is a complex disorder involving multiple genetic
and environmental components. Thus, many pathways and
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mechanisms are likely to be implicated in its etiology and
pathophysiology. Dysfunction of the SCO and abnormalities
in ependymal cells has been suggested to be major causes
of congenital obstructive hydrocephalus (Huh et al., 2009;
Jiménez et al., 2014). Aberrations in neural stem and progenitor
cell proliferation and survival have also been associated
with hydrocephalus. Thus, several reports have demonstrated
a reduction of neural progenitor proliferation as well as
increased cell death in hydrocephalus. As underlying associated
mechanisms abnormal cell-cell junctions between neural stem
cells and ependymal cells has been variously reported to
induce loss of these cells and their and detachment from the
VZ (Domínguez-Pinos et al., 2005; Rodríguez et al., 2012).
Subsequently, the disruption of the VZ in the walls of the
Sylvian aqueduct leads to obliteration and stenosis during
embryonic development (McAllister, 2012). Impaired neural
progenitor proliferation and loss of neural stem cells have
also been associated with non-obstructive hydrocephalus in
a mouse ciliopathy model as well as with other genetic
hydrocephalus models (Tian et al., 2011; Carter et al.,
2012).
Lack of Dusp16 expression in the CP and the normal
morphology of this structure, suggest that CSF overproduction
is not the cause of hydrocephalus in Dusp16−/− mutants.
Moreover, the lack of dilatation of the fourth ventricle suggests
that impaired reabsorption of CSF into the venous blood
stream is also not responsible for the ventricular dilatations
in these animals. In contrast, the occlusion of the midbrain
aqueduct, preceding ventricular enlargement, strongly suggests
that this is the cause of the hydrocephalus in Dusp16−/−
mutants.
In Dusp16−/− mutants we did not find any abnormalities
in ependymal cells and cell junctions. Similarly, the SCO
was formed and produced RF, leading us to conclude
that the overproliferation of neural progenitor cells we
observed causes the hydrocephalus in Dusp16−/− mutants.
This is strengthened by our finding that progenitor cells
and, later during development, mature neurons, obstruct
the midbrain aqueduct. Importantly, we observed that
proliferation of neural progenitor cells is first seen shortly
before the onset of occlusion. A reprogramming of SCO
cells to neurons seems unlikely as RF producing SCO cells
are not reduced, but are, rather, moved posterior to the
occlusion by over-proliferating cells. Thus our data support
obstruction of the midbrain aqueduct by over-proliferation of
neural progenitors as the proximal cause of hydrocephalus in
Dusp16−/− mutants.
A Potential Role for Dusp16 in the
Combination of Hydrocephalus and Brain
Overgrowth Disorders
The particular combination of hydrocephalus, brain overgrowth
and abnormal MAPKs signaling, found in Dusp16−/− mutants,
recapitulates aspects of different neurodevelopmental disorders.
Megalencephaly-polymicrogyria-polydactyl-hydrocephalus
(MPPH) syndrome in humans is a predominantly prenatal
developmental syndrome characterized by megalencephaly and
bilateral perisylvian polymicrogyria, caused by overproliferation
of the dorsal diencephalon and midbrain. Hydrocephalus
and polydactyly are more variable features seen in nearly half
of the reported individuals. De novo germline mutations in
three core PI3K-AKT-mTOR pathway genes are now known
to be associated with MPPH including, PIK3R2, AKT3 and
CCND2 (Mirzaa et al., 2014). CCND2 plays a major role in
neural progenitor proliferation and its increased expression in
Dusp16−/− embryos indicates that it is part of the molecular
mechanism causing neural overproliferation in these mutants.
The phosphorylation and subsequent inactivation of CCND2 by
GSK3-beta plays a key role in controlling CCND2 activity,
and dysregulation of this interaction has been implicated in
megalencephaly (Huang et al., 2007; Kida et al., 2007; Mirzaa
et al., 2014). Inhibition of GSK3-beta activity is the principle
mechanism regulating this kinase. Besides inhibition by the
protein kinase Akt at the N terminus (Ser9), p38 MAPK
also inactivates GSK3-beta by direct phosphorylation at
its C terminus (Thr389), occurring primarily in the brain
and in thymocytes (Thornton et al., 2008). These findings
suggest the possibility that in Dusp16−/− mutants altered
p38 MAPK / GSK3-beta interaction leads to an increased
CCND2, which has previously been causally linked to
MPPH.
The combination of MAPK pathway abnormalities,
hydrocephalus and brain overgrowth is also observed in
RASopathies. This clinically-defined group of syndromes
is caused by germline mutations in genes encoding
components or regulators of the Ras/MAPK pathway.
Many of these disorders show brain overgrowth combined
with hydrocephalus. They include Noonan syndrome,
Costello syndrome, cardiofaciocutaneous syndrome and
neurofibromatosis, type I (Winden et al., 2015; Kousi and
Katsanis, 2016). For the phenotype analysis of Dusp16−/−
mutants reported here, we focused on changes in embryonic
CNS development. A future, detailed analysis of the phenotype
of these mutants outside of the CNS will provide necessary
information, to follow up a potential role of DUSP16 in
RASopathies. Taken together, DUSP16 is a promising
candidate gene for a broad spectrum of disorders combining
hydrocephalus, brain overgrowth and abnormal MAPK
signaling.
Factors Upstream and Downstream of
DUSP16 in Neurogenesis
Along with others, we have demonstrated that growth factors,
including Bmps, Fgfs and Wnts, are the essential extracellular
regulators of neurogenesis in the midbrain by balancing neural
progenitor proliferation and differentiation (Panhuysen et al.,
2004; Saarimäki-Vire et al., 2007; Paridaen and Huttner, 2014).
A series of evidence indicates that growth factors induce the
expression of different Dusps including Dusp3 and Dusp6
during embryogenesis. In these experiments, the upregulation
of Dusps serves as a negative feedback regulator of growth
factor signaling (Li et al., 2007; Finelli et al., 2013). As would
have been expected from this antagonism, the conditional
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inactivation of Fgf receptors 1 and 2 leads to a phenotype
complementary to the one observed in Dusp16−/− mutants.
While in Fgf receptor mutants there is premature neuronal
differentiation and depletion of the progenitor pool (Lahti et al.,
2011), Dusp16−/− mutants show an increase in the progenitor
pool together with delayed neural differentiation. Due to the
regulatory role of the MAPK pathway that integrates different
signaling pathways, it seems likely that DUSPs are not only
involved in modulating Fgf signaling in the developing nervous
system, but also serve to integrate signals from different growth
factors.
Depending on the cellular context and type of growth
factor involved, Dusp16 appears to differentially impact on
cellular proliferation, since bone marrow cell proliferation
in response to GM-CSF was reduced in Dusp16−/− mice
(Niedzielska et al., 2014) and shRNA knockdown in several
cancer cell lines induced cellular senescence and cell cycle arrest
(Zhang et al., 2015). The mechanistic basis underlying these
strikingly different outcomes ofDusp16-deficiency remains to be
determined, but may be related to the specific MAPK proteins
involved.
Classical DUSPs containing a MAPK-binding domain
have high substrate specificity for MAPKs, with Dusp16
showing a preference for JNK and p38 MAPK (Masuda
et al., 2001; Matsuguchi et al., 2001; Tanoue et al., 2001;
Theodosiou and Ashworth, 2002). Based on the limitations
of immunohistochemistry for the quantification of signaling
components, we cannot prove by which substrate Dusp16
regulates neurogenesis. However, the abundant phosphorylation
of p38 MAPK in DUSP16−/− mutants and unaltered levels
of phosphor-JNK suggest that p38 MAPK is an obvious
candidate mediating the effects of Dusp16 on neurogenesis.
p38 MAPK is activated by various cytotoxic stresses, cytokines
and growth factors (Cuadrado and Nebreda, 2010; Coffey,
2014). In contrast to JNK signaling, which has been shown
to negatively regulate neuronal progenitor proliferation
(Coffey, 2014), the role of p38 MAPKs in neurogenesis is
less well understood. In particular, the role of p38 MAPK
in neural stem cell proliferation remains controversial.
p38 MAPK was initially shown to increase proliferation
in an immortalized neuronal cell line (Kim et al., 2008)
as well as in adult hippocampal stem cells (Zhang et al.,
2011). In contrast, p38 MAPK was also shown to decrease
proliferation in neural progenitors in primary embryonic
neuronal cultures (Sato et al., 2008) and in neurosphere
cultures of adult hippocampal cells (Yoshioka et al., 2015).
Based on our study p38 is a promising candidate to mediate
the effects of Dusp16 on neural development. Future studies
will provide necessary information about the functional role
of Dusp16 regulated p38 activity in neural development and
disorders.
In conclusion, we provide evidence that Dusp16 is necessary
for proper neural progenitor cell pool expansion, by regulating
their cell cycle exit. We further demonstrate that Dusp16
deficiency causes and combines congenital obstructive
hydrocephalus and brain overgrowth. Moreover, our results
establish Dusp16−/− mutants as a powerful tool to study
neurobiology and novel treatment strategies and suggest that
Dusp16 is a promising candidate gene for human genetic studies
investigating these pathologies.
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